Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function

被引:216
|
作者
Schebesta, Alexandra [1 ]
McManus, Shane [1 ]
Salvagiotto, Giorgia [1 ]
Delogu, Alessio [1 ]
Busslinger, Georg A. [1 ]
Busslinger, Meinrad [1 ]
机构
[1] Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.immuni.2007.05.019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The transcription factor Pax5 represses B lineage-inappropriate genes and activates B cell-specific genes in B lymphocytes. Here we have identified 170 Pax5-activated genes. Conditional mutagenesis demonstrated that the Pax5-regulated genes require continuous Pax5 activity for normal expression in pro-13 and mature B cells. Expression of half of the Pax5-activated genes is either absent or substantially reduced upon Pax5 loss in plasma cells. Direct Pax:5 target genes were identified based on their protein synthesis-independent activation by a Pax5-estrogen receptor fusion protein. Chromatin immunoprecipitation (ChIP) of Pax5 together with chromatin profiling by ChIP-on-chip analysis demonstrated that Pax5 directly activates the chromatin at promoters or putative enhancers of Pax5 target genes. The Pax5-activated genes code for key regulatory and structural proteins involved in B cell signaling, adhesion, migration, antigen presentation, and germinal-center B cell formation, thus revealing a complex regulatory network that is activated by Pax5 to control B cell development and function.
引用
收藏
页码:49 / 63
页数:15
相关论文
共 50 条
  • [21] B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling
    Cozma, Diana
    Yu, Duonan
    Hodawadekar, Suchita
    Azvolinsky, Anna
    Grande, Shannon
    Tobias, John W.
    Metzgar, Michele H.
    Paterson, Jennifer
    Erikson, Jan
    Marafioti, Teresa
    Monroe, John G.
    Atchison, Michael L.
    Thomas-Tikhonenko, Andrei
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (09): : 2602 - 2610
  • [22] Dominant-Negative Impact of PAX5/TEL on Downstream Targets of PAX5 and Essential Pre-B Cell Receptor Genes
    Iwanski, Gabriela B.
    Thoennissen, Nils H.
    Nakitandwe, Joy
    Lin, Patricia
    Kawamata, Norihiko
    Nahar, Rahul
    Ramezani-Rad, Parham
    Chen, Shann-Ching
    Shurtleff, Sheila
    Nowak, Daniel
    Ruckert, Christian
    Dugas, Martin
    Bokemeyer, Carsten
    Fazio, Grazia
    Biondi, Andrea
    Cazzaniga, Giovanni
    Downing, James R.
    Mueschen, Markus
    Koeffler, H. Phillip
    BLOOD, 2010, 116 (21) : 1325 - 1326
  • [23] Study of the activity of two isoforms of the transcription factor PAX5 in the terminal maturation of B lymphocytes
    Peron, S.
    Tinguely, A.
    Delabesse, E.
    Broccardo, C.
    Cogne, M.
    Delpy, L.
    IMMUNOLOGY, 2011, 135 : 69 - 69
  • [24] PAX5/TEL FUSION PROTEIN AFFECTS TRANSCRIPTION PROFILE OF PREBI CELLS, CAUSING AN OPPOSITE DOMINANT EFFECT ON PAX5 PATHWAY, A REDUCED ADHESION CAPACITY AND A BLOCK OF B CELL RECEPTOR ASSEMBLY
    Fazio, G.
    Cazzaniga, V.
    Bugarin, C.
    Palmi, C.
    Galbiati, M.
    Giordan, M.
    Kronnie, Te G.
    Rolink, A.
    Gaipa, G.
    Biondi, A.
    Cazzaniga, G.
    CYTOMETRY PART A, 2011, 79A (12) : 1048 - 1048
  • [25] Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5
    Pongubala, Jagan M. R.
    Northrup, Daniel L.
    Lancki, David W.
    Medina, Kay L.
    Treiber, Thomas
    Bertolino, Eric
    Thomas, Matthew
    Grosschedl, Rudolf
    Allman, David
    Singh, Harinder
    NATURE IMMUNOLOGY, 2008, 9 (02) : 203 - 215
  • [26] Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5
    Jagan M R Pongubala
    Daniel L Northrup
    David W Lancki
    Kay L Medina
    Thomas Treiber
    Eric Bertolino
    Matthew Thomas
    Rudolf Grosschedl
    David Allman
    Harinder Singh
    Nature Immunology, 2008, 9 : 203 - 215
  • [27] PAX5 promotes lymphomagenesis through the stimulation of B-cell receptor signaling
    Cozma, Diana
    Yu, Duonan
    Hodawadekar, Suchita
    Azvolinsky, Anna
    Grande, Shannon
    Tobias, John W.
    Metzgar, Michele H.
    Paterson, Jennifer
    Erikson, Jan
    Marafioti, Teresa
    Monroe, John G.
    Atchison, Michael L.
    Thomas-Tikhonenko, Andrei
    TUMOR BIOLOGY, 2007, 28 : 10 - 10
  • [28] PAX5/TEL Has An Opposite Dominant Effect on Endogenous PAX5, Affecting Its Transcriptional Regulation, B Cell Adhesion and BCR Signaling In Murine Pre-BI Cells.
    Fazio, Grazia
    Cazzaniga, Valeria
    Palmi, Chiara
    Galbiati, Marta
    Giordan, Marco
    Kronnie, Truus Te
    Rolink, Antonius
    Biondi, Andrea
    Cazzaniga, Giovanni
    BLOOD, 2010, 116 (21) : 1030 - 1030
  • [29] The PAX5 oncogene encodes circular RNA products involved in B cell cancer processes
    Martin, Danick
    Hannay, Brandon
    McGraw, Farrah
    Martin, Alexis
    Veilleux, Vanessa
    Finn, Nicholas
    Robichaud, Gilles A.
    CANCER RESEARCH, 2024, 84 (07)
  • [30] Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis
    Marta Isidro-Hernández
    Andrea Mayado
    Ana Casado-García
    Jorge Martínez-Cano
    Chiara Palmi
    Grazia Fazio
    Alberto Orfao
    Jordi Ribera
    Josep Maria Ribera
    Lurdes Zamora
    Javier Raboso-Gallego
    Oscar Blanco
    Diego Alonso-López
    Javier De Las Rivas
    Rafael Jiménez
    Francisco Javier García Criado
    María Begoña García Cenador
    Manuel Ramírez-Orellana
    Giovanni Cazzaniga
    César Cobaleda
    Carolina Vicente-Dueñas
    Isidro Sánchez-García
    Scientific Reports, 10